Profund Advisors
FULC icon

Profund Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Profund Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-32,514
Closed -$119K – 1145
2026
Q2 		$119K Buy
32,514
+17,013
+110% +$103K ﹤0.01% 1138
2026
Q1 		$119K Buy
+15,501
New +$144K ﹤0.01% 1063
2024
Q4 		– Sell
-34,846
Closed -$124K – 1146
2024
Q3 		$124K Buy
34,846
+23,925
+219% +$177K ﹤0.01% 1095
2024
Q2 		$67.7K Buy
+10,921
New +$82.7K ﹤0.01% 1062

Other funds holding FULC

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Castleview Partners
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Profund Advisors's FULC Position: Q3 2026 in Review

Profund Advisors sold out of Fulcrum Therapeutics (FULC) in Q3 2026, closing a stake of 32,514 shares — an estimated $119K sold.

Profund Advisors first reported a position in FULC in Q2 2024 and held it in 4 quarters. The position peaked at $124K in Q3 2024. 24 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Profund Advisors reported no remaining Fulcrum Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Profund Advisors sold 32,514 Fulcrum Therapeutics shares in Q3 2026, an estimated $119K.
  • Profund Advisors first reported a position in Fulcrum Therapeutics in Q2 2024 and held it in 4 quarters.
  • Profund Advisors's Fulcrum Therapeutics position peaked at $124K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.